Cycloset Approved for Type 2 Diabetes
Links shared publicly online about this topic
Cycloset Approved for Type 2 Diabetes - Health News - Health.com
news.health.com — “Cycloset (bromocriptine), a drug that takes the novel approach of managing blood sugar via the brain, has been approved by the U.S. Food and Drug Administration, maker VeroScience Inc. said Wednesday.” View full resource at news.health.com
Most Recently Shared on May 8, 2009 at 12:34 am By:
Cycloset Approved for Type 2 Diabetes: Cycloset (bromocriptine), a drug that takes the novel approach of managin.. http://tinyurl.com/dm54c7
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
medicalnewstoday.com — “Santarus, Inc. (NASDAQ: SNTS), S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manu” View full resource at medicalnewstoday.com
Most Recently Shared on September 10, 2010 at 5:00 pm By:
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET http://mnt.to/3JxK #diabetes
Cycloset available for type 2 diabetes - MPR
empr.com — “Santarus announced that Cycloset (bromocriptine mesylate tablets), a dopamine receptor agonist, has been made available for the management of type 2 diabetes as an adjunct to diet and exercise.” View full resource at empr.com
Most Recently Shared on November 16, 2010 at 2:54 pm By:
MPR News: Cycloset available for type 2 diabetes: Santarus announced that Cycloset (bromocriptine mesylate table... http://bit.ly/9SLZks
Cycloset available for type 2 diabetes - ONA
oncologynurseadvisor.com — “Santarus announced that Cycloset (bromocriptine mesylate tablets), a dopamine receptor agonist, has been made available for the management of type 2 diabetes as an adjunct to diet and exercise.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 16, 2010 at 2:59 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Cycloset available for type 2 diabetes http://goo.gl/fb/XRJEw
Novel Diabetes Drug Cycloset Approved :: Diabetes Self-Management
diabetesselfmanagement.com — “Last week, the u.s. food and drug administration (fda) approved a new drug for treating type 2 diabetes. called cycloset, the drug is actually a new version of the older drug bromocriptine, which has been used at higher doses to treat people with parkinson disease.” View full resource at diabetesselfmanagement.com
Most Recently Shared on May 17, 2009 at 6:58 pm By:
Novel Diabetes Drug Cycloset Approved - http://tinyurl.com/pmspbp
CYCLOSET - New Product Releases - MPR
empr.com — “Adjunct to diet and exercise, to improve glycemic control in type 2 diabetes.” View full resource at empr.com
Most Recently Shared on December 10, 2010 at 3:02 pm By:
MPR News: CYCLOSET: Bromocriptine (as mesylate) 0.8mg; tabs. http://bit.ly/dFlX1I
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET | Business Wire
businesswire.com — “Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today announced the commercial U.S. launch of CYCLOSET® (bromocriptine mesyl” View full resource at businesswire.com
Most Recently Shared on November 16, 2010 at 1:57 pm By:
Hope Warshaw Nutritionist and Dietitian
New diabetes drug enters market: Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET http://bit.ly/cjSjV4
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
drugs.com — “Onglyza (saxagliptin) is used to treat Type 2 diabetes. Includes Onglyza side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 1, 2009 at 3:03 am By:
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes - http://bit.ly/19lKrd
FDA Approves Tradjenta for Type 2 Diabetes
drugs.com — “Tradjenta (linagliptin) is used to treat type 2 diabetes. Includes Tradjenta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 3, 2011 at 2:22 am By:
FDA Approves Tradjenta for Type 2 Diabetes - http://bit.ly/jxwide
FDA Approves New Treatment For Type 2 Diabetes
medicalnewstoday.com — “The u.s. food and drug administration today approved victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.victoza is intended to help lower blood sugar le” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2010 at 3:09 pm By:
FDA Approves New Treatment For Type 2 Diabetes http://mnt.to/3wM5 #diabetes
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on November 15, 2010 at 8:48 pm By:
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET: SAN DIEGO… http://goo.gl/fb/OqIu9
Tradjenta Approved for Type 2 Diabetes - ONA
oncologynurseadvisor.com — “Boehringer Ingelheim and Eli Lilly announced that the FDA has approved Tradjenta (linagliptin tablets), a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 3, 2011 at 2:07 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Tradjenta Approved for Type 2 Diabetes http://goo.gl/fb/XQTFl
Tradjenta Approved for Type 2 Diabetes - MPR
empr.com — “Boehringer Ingelheim and Eli Lilly announced that the FDA has approved Tradjenta (linagliptin tablets), a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 2:38 pm By:
MPR News: Tradjenta Approved for Type 2 Diabetes: Boehringer Ingelheim and Eli Lilly announced that the FDA has ... http://bit.ly/iYELgu
Bydureon Approved for Type 2 Diabetes - Yahoo! News
news.yahoo.com — “From Yahoo! News: FRIDAY, Jan. 27 (HealthDay News) -- Bydureon (exenatide extended release), Amylin Pharmaceuticals' long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Administration.” View full resource at news.yahoo.com
Most Recently Shared on January 27, 2012 at 11:26 pm By:
Bydureon Approved for Type 2 Diabetes: FRIDAY, Jan. 27 (HealthDay News) -- Bydureon (exenatide extended release)... http://t.co/OSWGzmKz
FDA approved saxagliptin to treat type 2 diabetes
endocrinetoday.com — “Patients with type 2 diabetes now have a new treatment option: saxagliptin, a dipeptidyl peptidase-4 inhibitor that stimulates the pancreas to c” View full resource at endocrinetoday.com
Most Recently Shared on July 31, 2009 at 7:04 pm By:
Read more about the just-approved #diabetes drug, #saxagliptin: http://tinyurl.com/nw355h
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Walter Adamson
A diet-controlled type 2 diabete sharing my experience in managing the condition.
-
MNT Diabetes News
The latest diabetes news published daily. Articles from research centers, universities and prestigious journals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
